Novo Holdings Freeline Therapeutics Holdings PLC Transaction History

Novo Holdings

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.92 - $2.03 $1.63 Million - $3.61 Million	-1,776,613 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.97 - $3.45 $298,541 - $522,826	-151,544 Reduced 7.86%	1,776,613 $3.52 Million
Q3 2021 Nov 15, 2021	SELL	$3.04 - $8.9 $1.32 Million - $3.85 Million	-433,072 Reduced 18.34%	1,928,157 $6.58 Million
Q4 2020 Feb 16, 2021	BUY	$14.94 - $18.3 $25.3 Million - $31 Million	1,696,229 Added 255.07%	2,361,229 $43.1 Million
Q3 2020 Nov 16, 2020	BUY	$15.45 - $18.12 $10.3 Million - $12 Million	665,000 New	665,000 $10.4 Million

30.1K

Ticker FRLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,972,300
Description
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in P...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.